Education
About Us
Working with TipRanks
Follow Us
SynAct Pharma AB (DE:8F8)
FRANKFURT:8F8
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | kr 0.00 | kr 0.00 | kr 0.00 | kr 0.00 | kr 0.00 |
| Gross Profit | kr 0.00 | kr -778.00K | kr -1.06M | kr -88.00K | kr 0.00 |
| Operating Income | kr -89.98M | kr -224.50M | kr -105.70M | kr -76.70M | kr -31.29M |
| EBITDA | kr -15.40M | kr -222.70M | kr -105.71M | kr -76.62M | kr -30.90M |
| Net Income | kr -82.40M | kr -215.81M | kr -99.20M | kr -69.30M | kr -26.55M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | kr 61.21M | kr 62.40M | kr 108.25M | kr 24.00M | kr 14.55M |
| Total Assets | kr 270.52M | kr 228.02M | kr 142.60M | kr 38.37M | kr 21.59M |
| Total Debt | kr 1.88M | kr 637.00K | kr 2.06M | kr 3.09M | kr 0.00 |
| Net Debt | kr -59.33M | kr -61.76M | kr -106.18M | kr -20.91M | kr -14.55M |
| Total Liabilities | kr 56.35M | kr 51.83M | kr 16.08M | kr 17.50M | kr 5.72M |
| Stockholders' Equity | kr 214.17M | kr 176.19M | kr 126.52M | kr 20.87M | kr 15.87M |
| Cash Flow | |||||
| Free Cash Flow | kr -89.20M | kr -100.18M | kr -117.56M | kr -65.00M | kr -33.24M |
| Operating Cash Flow | kr -89.20M | kr -100.18M | kr -117.56M | kr -65.00M | kr -33.24M |
| Investing Cash Flow | kr 0.00 | kr 370.00K | kr 27.00K | kr -6.00K | kr -93.00K |
| Financing Cash Flow | kr 87.41M | kr 53.98M | kr 200.71M | kr 74.32M | kr 44.72M |